3 days in a row it is closing lower.
Profit taking may send MRNA to test previous resistance, which now may become a support level.
If all goes well, it should bounce off of 185, or a bit lower within BUY1 zone, and head to ATH in 250’s.
However, we may as well see a bigger sell off, like witnessed 2 times already back in Dec and Feb.
If that happens, MRNA may loose almost all of its gains of the last wave and head to 140’s-150’s, where BUY2 zone is indicated.
I do not expect it to drop more than that, unless there are any bad news (then it can test even lower support levels).
And after that, before or after the next earnings, we shall see ATH in 250’s.
Profit taking may send MRNA to test previous resistance, which now may become a support level.
If all goes well, it should bounce off of 185, or a bit lower within BUY1 zone, and head to ATH in 250’s.
However, we may as well see a bigger sell off, like witnessed 2 times already back in Dec and Feb.
If that happens, MRNA may loose almost all of its gains of the last wave and head to 140’s-150’s, where BUY2 zone is indicated.
I do not expect it to drop more than that, unless there are any bad news (then it can test even lower support levels).
And after that, before or after the next earnings, we shall see ATH in 250’s.
Next week we may see it in the BUY1 zone.
Depending on the development I may buy it again or wait for the BUY2 levels.